Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 3
2003 2
2004 6
2005 4
2006 3
2007 3
2008 2
2009 3
2010 3
2011 4
2012 3
2013 3
2015 5
2016 5
2017 6
2018 8
2019 9
2020 3
2021 4
2022 9
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Results by year
Filters applied: . Clear all
Page 1
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
Bionic Pancreas Research Group; Russell SJ, Beck RW, Damiano ER, El-Khatib FH, Ruedy KJ, Balliro CA, Li Z, Calhoun P, Wadwa RP, Buckingham B, Zhou K, Daniels M, Raskin P, White PC, Lynch J, Pettus J, Hirsch IB, Goland R, Buse JB, Kruger D, Mauras N, Muir A, McGill JB, Cogen F, Weissberg-Benchell J, Sherwood JS, Castellanos LE, Hillard MA, Tuffaha M, Putman MS, Sands MY, Forlenza G, Slover R, Messer LH, Cobry E, Shah VN, Polsky S, Lal R, Ekhlaspour L, Hughes MS, Basina M, Hatipoglu B, Olansky L, Bhangoo A, Forghani N, Kashmiri H, Sutton F, Choudhary A, Penn J, Jafri R, Rayas M, Escaname E, Kerr C, Favela-Prezas R, Boeder S, Trikudanathan S, Williams KM, Leibel N, Kirkman MS, Bergamo K, Klein KR, Dostou JM, Machineni S, Young LA, Diner JC, Bhan A, Jones JK, Benson M, Bird K, Englert K, Permuy J, Cossen K, Felner E, Salam M, Silverstein JM, Adamson S, Cedeno A, Meighan S, Dauber A. Bionic Pancreas Research Group, et al. N Engl J Med. 2022 Sep 29;387(13):1161-1172. doi: 10.1056/NEJMoa2205225. N Engl J Med. 2022. PMID: 36170500 Clinical Trial.
BACKGROUND: Currently available semiautomated insulin-delivery systems require individualized insulin regimens for the initialization of therapy and meal doses based on carbohydrate counting for routine operation. ...METHODS: In this 13-week, multicenter, randomized …
BACKGROUND: Currently available semiautomated insulin-delivery systems require individualized insulin regimens for the initial …
Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.
Razavi Z, Maher S, Fredmal J. Razavi Z, et al. Endocrine. 2018 Aug;61(2):267-274. doi: 10.1007/s12020-018-1635-z. Epub 2018 May 24. Endocrine. 2018. PMID: 29797212 Clinical Trial.
PURPOSE: To compare the safety/efficacy of intermittent subcutaneous rapid-acting insulin aspart with the standard low-dose intravenous infusion protocol of regular insulin for treatment of pediatric diabetic-ketoacidosis. ...CONCLUSIONS: To man …
PURPOSE: To compare the safety/efficacy of intermittent subcutaneous rapid-acting insulin aspart with the standard low-dose in …
Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Andrade-Castellanos CA, et al. Cochrane Database Syst Rev. 2016 Jan 21;2016(1):CD011281. doi: 10.1002/14651858.CD011281.pub2. Cochrane Database Syst Rev. 2016. PMID: 26798030 Free PMC article. Review.
Four trials evaluated the effects of the rapid-acting insulin analogue lispro, and one the effects of the rapid-acting insulin analogue aspart. ...In one trial involving children with DKA, the time to reach a glucose level of 250 mg/dL was simil …
Four trials evaluated the effects of the rapid-acting insulin analogue lispro, and one the effects of the rapid-acting insu …
Aspart Insulin.
Rubin R, Khanna NR, McIver LA. Rubin R, et al. 2022 Nov 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. 2022 Nov 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 29763206 Free Books & Documents.
Insulin aspart is a rapid-acting, human insulin analog that is FDA approved to treat type-1 and type-2 diabetes mellitus to improve glycemic control in adults and children. Insulin aspart may also be used to treat diabetic ketoacidosis …
Insulin aspart is a rapid-acting, human insulin analog that is FDA approved to treat type-1 and type-2 diabetes mellitu …
Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC, McKay A, Ridyard C, Thornborough K, Bedson E, Peak M, Didi M, Annan F, Gregory JW, Hughes DA, Gamble C; SCIPI investigators. Blair JC, et al. BMJ. 2019 Apr 3;365:l1226. doi: 10.1136/bmj.l1226. BMJ. 2019. PMID: 30944112 Free PMC article. Clinical Trial.
Secondary outcomes were percentage of patients in each treatment arm with HbA1c within the national target range, incidence of severe hypoglycaemia and diabetic ketoacidosis, change in height and body mass index (as measured by standard deviation scores), insulin …
Secondary outcomes were percentage of patients in each treatment arm with HbA1c within the national target range, incidence of severe hypogl …
Lispro insulin and electrolyte supplementation for treatment of diabetic ketoacidosis in cats.
Anderson JD, Rondeau DA, Hess RS. Anderson JD, et al. J Vet Intern Med. 2019 Jul;33(4):1593-1601. doi: 10.1111/jvim.15518. Epub 2019 May 27. J Vet Intern Med. 2019. PMID: 31134702 Free PMC article.
BACKGROUND: Intravenous continuous rate infusion (IVCRI) of lispro at a starting dose of 0.09 U/kg/h and the use of 0.9% sodium chloride (NaCl) for fluid resuscitation in cats with diabetic ketoacidosis (DKA) have not been reported. ...METHODS: Randomi …
BACKGROUND: Intravenous continuous rate infusion (IVCRI) of lispro at a starting dose of 0.09 U/kg/h and the use of 0.9% sodium chlor …
Insulin Lispro.
Islam N, Khanna NR, Zito PM. Islam N, et al. 2022 Aug 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. 2022 Aug 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 29939617 Free Books & Documents.
Insulin lispro is an insulin analog that is FDA-approved for the treatment of patients with diabetes mellitus types 1 and 2 to control hyperglycemia. ...One unit of insulin lispro is as potent as one unit of human insulin in lowering gluc …
Insulin lispro is an insulin analog that is FDA-approved for the treatment of patients with diabetes mellitus types 1 a …
Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L, Dicembrini I, Mannucci E. Pala L, et al. Acta Diabetol. 2019 Sep;56(9):973-980. doi: 10.1007/s00592-019-01326-5. Epub 2019 Apr 3. Acta Diabetol. 2019. PMID: 30945047
On the other hand, CSII is associated with a small, but relevant risk of ketoacidosis, mainly due to malfunction of insulin pump and/or catheter occlusion. ...With respect to severe hypoglycemia, CSII did not produce a significant reduction of risk in comparison wit …
On the other hand, CSII is associated with a small, but relevant risk of ketoacidosis, mainly due to malfunction of insulin pu …
Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2.
Warren M, Bode B, Cho JI, Liu R, Tobian J, Hardy T, Chigutsa F, Phillip M, Horowitz B, Ignaut D. Warren M, et al. Diabetes Obes Metab. 2021 Jul;23(7):1552-1561. doi: 10.1111/dom.14368. Epub 2021 Mar 23. Diabetes Obes Metab. 2021. PMID: 33687783 Free PMC article. Clinical Trial.
AIM: To evaluate the efficacy and safety of ultra rapid lispro (URLi) versus lispro (Humalog() ) in people with type 1 diabetes on continuous subcutaneous insulin infusion (CSII). ...The incidence of treatment-emergent adverse events was higher with URLi (60. …
AIM: To evaluate the efficacy and safety of ultra rapid lispro (URLi) versus lispro (Humalog() ) in people with type 1 diabete …
Efficacy and Safety of Intramuscular Insulin Lispro vs. Continuous Intravenous Regular Insulin for the Treatment of Dogs With Diabetic Ketoacidosis.
Malerba E, Alessandrini F, Grossi G, Giunti M, Fracassi F. Malerba E, et al. Front Vet Sci. 2020 Oct 16;7:559008. doi: 10.3389/fvets.2020.559008. eCollection 2020. Front Vet Sci. 2020. PMID: 33195532 Free PMC article.
The use of rapid-acting insulin analogs as routes of administration other than IV has never been described for the treatment of dogs with diabetic ketoacidosis (DKA). ...Client-owned dogs with naturally occurring DKA were included. Dogs treated …
The use of rapid-acting insulin analogs as routes of administration other than IV has never been described for the treatment of dogs …
79 results